製剤設計学講座

Keyphrases

1. Active Pharmaceutical Ingredients 33%
2. Time-domain nuclear Magnetic Resonance (TD-NMR) 33%
3. Magnetic Resonance Imaging 32%
4. Kohonen Self-organizing Map 28%
5. Disintegration Time 25%
6. Tensile Strength 24%
7. Tablet Properties 23%
8. Response Surface Methodology 22%
9. Insulin 20%
10. T2 Relaxation Time 20%
11. Finite Element Method 19%
12. Ointment 18%
13. Emulsion 16%
14. Indomethacin 15%
15. Cholesterol 15%
16. Menthol 15%
17. Causal Factors 14%
18. Photocrosslinking 14%
19. Formulation Optimization 14%
20. Design Space 13%
21. Orally Disintegrating Tablet 13%
22. Response Variable 13%
23. Theophylline 13%
24. Manufacturing Process 13%
25. Phase Separation 13%
26. Carboxymethylation 12%
27. Disintegrant 12%
28. Microcrystalline Cellulose 12%
29. Tablet Characteristics 12%
30. Formulation Factors 12%
31. Nonlinear Response Surfaces 12%
32. Water State 11%
33. Acetaminophen 11%
34. Response Surface 11%
35. Polyacrylamide Hydrogel 11%
36. Moisturizing Cream 10%
37. Granules 10%
38. Multivariate Splines 10%
39. Ceramide 10%
40. Mannitol 10%
41. Thin Plate Spline Interpolation 10%
42. Centrifugation 10%
43. Tablet-based 10%
44. Stratum Corneum 10%
45. Physical Stability 10%
46. Self-organizing Map Analysis 10%
47. Tablet Formulation 10%
48. Docosahexaenoic Acid 10%
49. Bayesian Network 9%
50. Residual Stress Distribution 9%
51. Latent Structure Analysis 9%
52. Bootstrap 9%
53. Poly(2-hydroxyethyl methacrylate) 9%
54. Infusion Fluid 9%
55. Self-organizing Clustering 9%
56. Cream Formulation 9%
57. Oilfield Produced Water 9%
58. T1 Relaxation Time 9%
59. Microstructure 9%
60. Crystalline State 8%
61. Intercellular Lipid 8%
62. Spline Interpolation 8%
63. Bootstrap Resampling Method 8%
64. Latent Structure 8%
65. Disintegration 8%
66. Liposomes 8%
67. κ-carrageenan 7%
68. Nanoparticles 7%
69. Granulation Process 7%
70. Relaxation Curve 7%
71. Placebo 7%
72. Pharmacological Effects 7%
73. Microparticles 7%
74. Pharmaceutical Properties 7%
75. Biopharmaceutical Development 7%
76. Skin Permeation 7%
77. Physical Properties 7%
78. Model Membranes 7%
79. Critical Quality Attributes 7%
80. Corn Starch 7%
81. Relaxation Behavior 7%
82. Insulin Delivery 7%
83. Chitosan 7%
84. Oral Insulin Delivery 6%
85. Lipid Model 6%
86. Pharmaceutical Study 6%
87. Physicochemical Properties 6%
88. Self-organizing Map 6%
89. Nondestructive Monitoring 6%
90. Solid Dispersion 6%
91. Iota-carrageenan 6%
92. Water Molecule 6%
93. Diltiazem Hydrochloride 6%
94. Propylene Glycol 6%
95. Definitive Screening Design 6%
96. Pharmaceutical Emulsions 6%
97. Scored Tablets 6%
98. Clobetasol Propionate Cream 6%
99. Multivariate Data 6%
100. Oral Formulation 6%

Pharmacology, Toxicology and Pharmaceutical Science

1. Tablet 100%
2. Indometacin 19%
3. Disintegrating Agent 14%
4. Carrageenan 13%
5. Polyacrylic Acid 12%
6. Microcrystalline Cellulose 11%
7. Adhesive Agent 11%
8. Theophylline 10%
9. Paracetamol 10%
10. Infusion Fluid 9%
11. Drug Release 9%
12. Dosage Forms 8%
13. Ceramide 8%
14. Starch 8%
15. Surfactant 8%
16. Mannitol 7%
17. Microparticle 7%
18. Base 7%
19. Lactose 7%
20. Infrared Spectroscopy 7%
21. Placebo 7%
22. Chitosan 7%
23. Pruritus 6%
24. Chronic Kidney Failure 6%
25. Hydrophilic-Lipophilic Balance 6%
26. Docosahexaenoic Acid 6%
27. Nanoparticle 6%
28. Clobetasone Butyrate 6%
29. Clobetasol Propionate 6%
30. Menthol 6%
31. Phenytoin 6%
32. Meloxicam 6%
33. Diphenhydramine 6%
34. Polymacon 6%
35. Diltiazem 6%
36. Propylene Glycol 6%
37. 2 Hydroxyethyl Methacrylate 5%
38. Water Oil Cream 5%
39. Dextran 5%
40. Excipient 5%
41. Oleic Acid 5%